Opposition · USPTO

Opposition 91195686

OtherUSPTO

Opposition 91195686 at USPTO between Inspire Pharmaceuticals, Inc. and Acclarent, Inc., over the mark INSPIRA BREEZE, filed Jul 15, 2010. Status in the office record: other.

View INSPIRA BREEZEGet this data via the API
Status
Other
Result
Other
Filed
Jul 15, 2010
Marks involved
8
Parties

Who is involved

The parties as named in the office record.

Opponent

Inspire Pharmaceuticals, Inc.

Respondent

Acclarent, Inc.

Company trademarks
Timeline

How the case has moved

Dates from the USPTO record and the INSPIRA BREEZE filing.

  1. INSPIRA BREEZE filed

    Application 77771916 filed at the USPTO.

  2. Opposition filed

    Inspire Pharmaceuticals, Inc. started opposition 91195686 at USPTO against INSPIRA BREEZE.
Marks

Marks involved

1 contested mark, 7 marks the challenger relies on.

MarkRoleApplicationOffice
INSPIRA BREEZEContested77771916USPTO
INSPIRE PHARMACEUTICALS, INC.Relied on75096301USPTO
INSPIRERelied on76308782USPTO
INSPIRERelied on76308918USPTO
INSPIRERelied on76308923USPTO
INSPIRERelied on76309035USPTO
INSPIRERelied on76618379USPTO
INSPIRERelied on76618380USPTO
API

Get this data via the API

Every fact on this page comes from the Signa API. Track oppositions and cancellations on any mark with one request.

  • GET/v1/proceedings/{id}

    Parties, dates, outcome and every mark in the case

  • GET/v1/proceedings?trademark_id={trademark_id}

    Every proceeding on a mark

Get API keyView docs
GET /v1/proceedings/{id}
ID=prc_8dc2b0d6-5183-4007-ada2-bd0d93482b55
curl https://api.signa.so/v1/proceedings/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "prc_8dc2b0d6-5183-4007-ada2-bd0d93482b55",
  "object": "proceeding",
  "proceeding_type": "opposition",
  "proceeding_number": "91195686",
  "status": "other",
  "office_code": "US",
  "filed_date": "2010-07-15",
  "parties": [
    {
      "name": "Inspire Pharmaceuticals, Inc.",
      "role": "opponent"
    },
    {
      "name": "Acclarent, Inc.",
      "role": "respondent"
    }
  ]
}